| 09 Octobre 2017
 9 OCTOBER 2017 | Cox’s Bazar, Bangladesh – The vaccine has arrived.  Micro-plans are complete. And hundreds of health workers and volunteers  have been mobilized and trained to carry out an epic mission: The  delivery of 900 000 doses of oral cholera vaccine (OCV) to more than 650  000 men, women and children now crowded into settlements and camps near  Cox’s Bazar, Bangladesh.
9 OCTOBER 2017 | Cox’s Bazar, Bangladesh – The vaccine has arrived.  Micro-plans are complete. And hundreds of health workers and volunteers  have been mobilized and trained to carry out an epic mission: The  delivery of 900 000 doses of oral cholera vaccine (OCV) to more than 650  000 men, women and children now crowded into settlements and camps near  Cox’s Bazar, Bangladesh.
 
 Less than 24 hours from the campaign’s 10 October start, Dr Roderico  Ofrin, Regional Emergency Director for WHO South-East Asia, is  systematic. “We have assessed the risk. We have procured the vaccine. We  have mobilized the vaccinators and are sensitizing communities. The  Ministry of Health and Family Welfare, WHO and partner agencies are  working with machine-like efficiency to stop any chance the diarrheal  disease has of taking root,” he says. “Given the risks, the intervention  will likely save many, many lives.”
 
 Since late August more than half a million people have poured into  Bangladesh from Rakhine state, Myanmar. They’ve joined hundreds of  thousands of people already crowded into camps and settlements in the  Cox’s Bazar area, further straining access to safe water, sanitation and  hygiene (WASH). As outlined in a risk assessment carried out by  national authorities and supported by WHO, UNICEF, IOM and MSF, the  potential for cholera to take hold is real; the need to act urgent.
 
 Speaking after the vaccine’s arrival in Dhaka on Saturday, WHO  Representative to Bangladesh Dr N Paranietharan says the Health Sector’s  drive, focus and unity made the intervention possible. “From the onset  of this emergency WHO, UNICEF and other Health Sector partners have been  working hand-in-glove with the Ministry and with each other to protect,  promote and secure health. That has allowed us to be bold and dynamic  in our approach,” he says. “The decisiveness and efficiency with which  the campaign has been planned reflects the Sector’s ability to respond  to facts on the ground with maximum impact.”
 
 Come Tuesday that impact will be delivered with full force. More than  200 mobile vaccination teams will fan-out across 12 camps and  settlements to shake, pop and deliver 650 000 thumb-size vials of the  vaccine. That initial phase will be followed by a second round later  this month targeting 250 000 children between one and five years old,  for whom the second dose provides added protection.
 
 It is critical that the campaign – which is the second largest of its  kind, ever – is accompanied by a full-volume scale up in WASH. “Mass  vaccination will provide vital protection against cholera, especially  for the next six months,” Dr Ofrin says. “But it is not a substitute for  clean water, adequate sanitation and good hygiene. Diarrheal diseases  other than cholera can still spread, meaning there is no time for  complacency. WASH must be scaled up and fortified immediately.”
 
 WHO’s technical and operational support to the campaign is part of its  immediate and ongoing emergency health response. Since August WHO has  helped plan and implement a measles, rubella and polio campaign that has  provided life-saving protection to more than 100 000 children. It has  mobilized essential medicines and medical supplies to brace health  services delivery at all levels, from basic to tertiary. And it has  rolled-out an Early Warning, Alert and Response System that will ensure a  rapid response if and when a disease outbreak occurs. To strengthen  these and other life-saving interventions, WHO is appealing for USD 10.2  million.
 
 “As the first responder and provider of last resort, WHO has mobilized  its full technical and operational capacity to support pressing health  needs,” says Dr Poonam Khetrapal Singh, Regional Director for WHO  South-East Asia. “The OCV campaign is a massive undertaking, but it is  one that is prudent given the risks. WHO is fully committed to  protecting and promoting the health and wellbeing of this immensely  vulnerable population.”









